Speakers

Expand/Collapse

Christina Fawcett
Senior Director, Decentralized Clinical Trial Operations
PRA Health Sciences

Day Two

Thursday, September 9, 2021

10:00 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs

Isaac Rodriguez-Chavez
Senior Vice President of Scientific & Clinical Affairs
PRA Health Sciences

Day One

Wednesday, September 8, 2021

10:25 am | Morning Q&A and Panel Forum

9:50 am | Innovation & High Impact on Patients’ Health Journey: Integrating Decentralized Clinical Trials (DCTs) with Clinical Research as a Care Option (CRAACO)

8:45 am | Chair’s Opening Remarks

Steven R. Cummings
Executive Director, San Francisco Coordinating Center
California Pacific Medical Center Research Institute

Day One

Wednesday, September 8, 2021

4:40 pm | Chair’s Closing Remarks

2:30 pm | Afternoon Q&A Panel Forum

1:40 pm | Removing Complexity: The Art of Cutting Tethers to the Trial Site

Amir Lahav
Healthcare Intelligence and Digital Transformation Consultant
Mitsubishi Tanabe Pharma America

Day Two

Thursday, September 9, 2021

10:00 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs

9:50 am | Morning Q&A & Panel Forum

9:00 am | New Trends in Remote Digital Monitoring Technology for Decentralized Trials in Patients with Neurodegenerative Diseases

8:50 am | Chair’s Opening Remarks

Tracey Robertson
Head of Digital Trials - Global Biostatistics & Data Sciences
Boehringer Ingelheim

Day One

Wednesday, September 8, 2021

4:20 pm | Closing Q&A & Panel Forum

3:55 pm | Designing a Hybrid Trial to Support Patient Choice

11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?

Day Two

Thursday, September 9, 2021

3:45 pm | Chair’s Closing Remarks

10:00 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs

Rachel Chasse
Director of Innovation
Digital Medicine Society (DiMe)

Day One

Wednesday, September 8, 2021

10:25 am | Morning Q&A and Panel Forum

9:25 am | DiMe on DCTs: Your How-To Guide

Daniel R Karlin
MD MA Chief Medical Officer
MindMed

Day Two

Thursday, September 9, 2021

3:00 pm | Panel: Too Hybrid, or Not to Hybridize?

2:45 pm | Afternoon Q&A & Panel Forum

1:30 pm | DCTs as Agile Clinical Experiments to Develop Novel Methods

Arturo Loaiza-Bonilla
Enterprise Director of Research
Cancer Treatment Centers of America

Day One

Wednesday, September 8, 2021

4:20 pm | Closing Q&A & Panel Forum

3:30 pm | Best Strategies to Optimize Patient Enrolment & Health Care Provider Engagement in the Digital Era: A Case Study

Mary C. Birmingham
PharmD, Director, Clinical Scientist
Janssen Scientific Affairs LLC

Day One

Wednesday, September 8, 2021

11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?

10:25 am | Morning Q&A and Panel Forum

9:00 am | Execution of a Randomized Decentralized Clinical Trial - a J&J Case Study

Rebecca Jackson
Clinical R&D SME - Clinical Data IT, Clinical Trials, Clinical Supply Chain
Johnson & Johnson

Day Two

Thursday, September 9, 2021

9:50 am | Morning Q&A & Panel Forum

9:25 am | Exploring the IMI Trials@Home Initiative

Jim Ternyila
Senior Business Relationship Manager - Digital Therapeutics
AstraZeneca

Day Two

Thursday, September 9, 2021

11:30 am | Using Vendors: What to Ask Them and What to Look For?

Amy Bohn
Study Operations Specialist, DCT Clinical Development
Bayer

Day One

Wednesday, September 8, 2021

12:10 pm | Evaluating Clinical Trials for a Decentralized Approach

Day Two

Thursday, September 9, 2021

3:00 pm | Panel: Too Hybrid, or Not to Hybridize?

Erica Lawson
Director, Applied Innovation
Otsuka

Day Two

Thursday, September 9, 2021

10:00 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs

Arthur Combs
MD President
FutureTech Strategies, Inc.

Day Two

Thursday, September 9, 2021

3:00 pm | Panel: Too Hybrid, or Not to Hybridize?

Craig Lipset
Co-Chair
Decentralized Trials & Research Alliance (DTRA)

Day Two

Thursday, September 9, 2021

2:45 pm | Afternoon Q&A & Panel Forum

1:55 pm | Collaboration to Accelerate the Global Adoption of Decentralized Trials

Jim Hacunda
R&D Digital Strategy Lead
Takeda

Day One

Wednesday, September 8, 2021

2:30 pm | Afternoon Q&A Panel Forum

2:05 pm | Using Systems Modelling to Compare & Contrast Centralized vs Decentralized Clinical Trials

Vera Rulon
Founder and President
Tir Health Advisors

Ruth Schneider
MD, Assistant Professor of Neurology
University of Rochester

Day Two

Thursday, September 9, 2021

2:45 pm | Afternoon Q&A & Panel Forum

2:20 pm | Lessons from Observational, Remote Research Studies in Neurodegenerative Diseases

Gunilla Andrew-Nielsen
Head of Department of Clinical Trials and Special Permissions
Medical Products Agency

Day One

Wednesday, September 8, 2021

4:20 pm | Closing Q&A & Panel Forum

2:40 pm | Case Studies from Running Patient Centric Clinical Trials Supported by Remote & Virtual Elements

Jen Horonjeff
Founder & CEO
Savvy Cooperative

Day One

Wednesday, September 8, 2021

4:20 pm | Closing Q&A & Panel Forum

3:05 pm | Some ‘Savvy’ Solutions to Providing Your Patients with Choice in a Decentralized Clinical Trial

11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?

Brandon Maggio
Director of Digital & Process Optimization
GSK

Day One

Wednesday, September 8, 2021

11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?

Shoibal Datta
Head, R&D Digital Strategy Group, Data Sciences Institute
Takeda

Day Two

Thursday, September 9, 2021

10:00 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs